SKM-1 Cells
USUSD$500.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
一般資訊
| 說明 | The SKM-1 cell line is a human leukemia model established from the peripheral blood of a patient with acute monoblastic leukemia that developed from myelodysplastic syndrome (MDS). These cells exhibit immature morphological features, such as a high nucleus-to-cytoplasm ratio and fine azurophilic granules, making them an excellent model for studying the molecular and cellular mechanisms of leukemia, particularly the transition from MDS to acute myeloid leukemia (AML). Genetic analysis of SKM-1 has revealed important chromosomal abnormalities, including del(9)(q13;q22) and der(17)t(17:?)(p13:?); the latter alteration involves the p53 gene, which is overexpressed and harbors mutations in this cell line. These findings highlight the role of p53 in clonal evolution and progression of myeloid malignancies. SKM-1 cells are also characterized by their expression of myelomonocytic markers, including CD4, CD13, and CD33, as well as their positivity for butyrate esterase activity, which aligns with their monoblastic lineage. This cell line is widely used in research on leukemogenesis, drug resistance, and the molecular pathways underlying leukemia. For instance, SKM-1 provides a platform for exploring the impacts of p53 dysfunction and other genetic lesions on cell proliferation and therapeutic response. It also serves as a model for investigating novel therapeutic strategies for myelodysplastic syndromes and secondary AML. |
|---|---|
| 生物體 | Human |
| 組織 | Peripheral blood |
| 疾病 | acute myleoid leukemia |
| 同義詞 | SKM1 |
特徵
| 年齡 | 76 years |
|---|---|
| 性別 | Male |
| 族裔 | Japanese |
| 形態學 | Round cells |
| 生長特性 | Suspension |
監管數據
| 引用 | SKM-1 (Cytion catalog number 305627) |
|---|---|
| 生物安全等級 | 1 |
| NCBI_TaxID | 9606 |
| Cellosaurus 編號 | CVCL_0098 |
生物分子資料
| 抗原表達 | CD3 -, CD4 (+), CD13 +, CD14 -, CD15 +, CD19 -, CD33 +, HLA-DR +; |
|---|---|
| 病毒 | EBV -, HBV -, HCV -, HIV-1 -, HIV-2 -, HTLV-1/2 -, MLV -, SMRV - |
| 突變譜 | Mutation: ASXL1, Simple, p.Tyr591Ter (c.1773C>A), Homozygous; Mutation: BCORL1, Simple, c.4619-1G>A, Homozygous, Splice acceptor Mutation; Mutation: EZH2, Simple, p.Tyr646Cys (c.1937A>G), Heterozygous; Mutation: KRAS, Simple, p.Lys117Asn (c.351A>C), Homozygous; Mutation: TP53, Simple, p.Arg248Gln (c.743G>A), Homozygous |
處理方式
| 培養基 | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| 營養補充品 | Supplement the medium with 15% FBS |
| 解離試劑 | None |
| 倍增時間 | 48 hours |
| 播種密度 | 0.3 to 1 x 106 cells/ml |
| 流體更新 | 2 to 3 times per week |
| 冷凍培養基 | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| 細胞解凍與培養 |
|
| 培養環境 | 37°C, 5% CO2, humidified atmosphere. |
| 運送條款 | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| 儲存條件 | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
品質控制與分子分析
| 不孕症 | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
分析證明書 (CoA)
| 批次編號 | 證書類型 | 日期 | 型號 |
|---|---|---|---|
| 305627-060226 | 分析證明書 | 05. Mar. 2026 | 305627 |
-
Related products
Related products